First-in-human clinical trial design of a first-in-class theranostic approach with a peptide-based radioligand targeting CA IX-expressing tumors Meeting Abstract
| Authors: | Feldman, D. R.; Tran, B.; Emmett, L.; Hofman, M. S.; Olivier, P.; Mahammedi, H.; Galetic, I.; Pokorska-Bocci, A.; Bouisset, F.; Gollmer, K.; Pavlyuk, M.; Tauchmanova, L.; Herrmann, K. |
| Abstract Title: | First-in-human clinical trial design of a first-in-class theranostic approach with a peptide-based radioligand targeting CA IX-expressing tumors |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.TPS3160 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: TPS3160 -- Meeting was also available virtually -- Source: Cinahl |
